INS and type 2 diabetes mellitus: Analysis of the correlation between the titer of anti-insulin antibodies as a function of the duration of insulin treatment showed a weak but statistically significant negative correlation in T1D patients, but not in T2D patients over a period of up to 68 and 30 years, respectively (Figure 1C and Figure 1D).